BrightMeds Three-Month GLP-1 Plan: Prepaid Rates vs Monthly Terms

Last reviewed: September 4, 2026 Last updated: September 4, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

BrightMeds' three-month prepaid plan charges $297 upfront for compounded semaglutide (a $99/month prepaid rate) or $357 upfront for compounded tirzepatide (a $119/month prepaid rate), captured September 4, 2026. The offer is described as a state-limited summer promotion. BrightMeds also offers month-to-month billing at $129/month for semaglutide and $149/month for tirzepatide, with no prepayment. All prices include medication, provider evaluation, follow-ups, dose adjustments, support, and shipping; no membership, lab, or prescribing fees apply. The same price covers any dose. Over 12 months, the prepaid plan costs $1,188 for semaglutide or $1,428 for tirzepatide (our calculation, assuming four consecutive three-month cycles), compared to $1,548 or $1,788 on month-to-month billing. PlexusDx semaglutide injection is $189/month month-to-month, $169/month on a three-month commitment, or $149/month on a six-month commitment; tirzepatide injection is $289/month month-to-month, $269/month on a three-month commitment, or $249/month on a six-month commitment. BrightMeds' prepaid promotional rate represents a significant price advantage, contingent on upfront payment and continued promotional availability.

At-a-glance comparison

BrightMeds pricing captured September 4, 2026; PlexusDx pricing current as of September 4, 2026. Prepaid rates are our calculation based on total upfront cost divided by months covered.

BrightMeds three-month plan: prepaid pricing breakdown

BrightMeds' three-month prepaid plan requires full payment at the start of each quarter. For compounded semaglutide injection, the upfront charge is $297, yielding a $99/month prepaid rate (our calculation: $297 ÷ 3 months). For compounded tirzepatide injection, the upfront charge is $357, yielding a $119/month prepaid rate (our calculation: $357 ÷ 3 months). Both prices were captured September 4, 2026, from BrightMeds' pricing page and promotional materials.

The pricing is described as a state-limited summer promotion. BrightMeds has not published whether the promotional rate will continue beyond the summer period, the specific states where the offer is available, or whether existing patients on the promotional rate will be grandfathered if the promotion ends. Prospective patients should confirm availability and ongoing rate terms at enrollment.

The prepaid plan includes medication, provider evaluation, follow-up visits, dose adjustments, ongoing support, and shipping. No membership fee, lab fee, or prescribing fee applies. The same price covers any dose within the standard titration protocol, so patients do not pay more as they escalate.

BrightMeds month-to-month plan: standard ongoing rates

BrightMeds also offers a month-to-month plan with no prepayment requirement. Compounded semaglutide injection costs $129/month; compounded tirzepatide injection costs $149/month (both captured September 4, 2026). The month-to-month plan includes the same services—medication, evaluation, follow-up, adjustments, support, and shipping—with no added fees.

The month-to-month option provides flexibility for patients who prefer not to commit upfront capital or who want to test the medication and service quality before a longer commitment. However, over 12 months, the month-to-month plan costs $360 more for semaglutide and $360 more for tirzepatide than four consecutive prepaid quarters (our calculation, detailed below).

12-month cost comparison: prepaid vs month-to-month

We calculated total 12-month cost assuming continuous treatment on each billing structure. All figures are our calculation.

BrightMeds semaglutide injection

• Three-month prepaid plan: $297 × 4 quarters = $1,188 total over 12 months ($99/month effective, prepaid rate)
• Month-to-month plan: $129 × 12 months = $1,548 total over 12 months ($129/month effective)
• Savings with prepaid plan: $1,548 − $1,188 = $360 over 12 months (our calculation)

BrightMeds tirzepatide injection

• Three-month prepaid plan: $357 × 4 quarters = $1,428 total over 12 months ($119/month effective, prepaid rate)
• Month-to-month plan: $149 × 12 months = $1,788 total over 12 months ($149/month effective)
• Savings with prepaid plan: $1,788 − $1,428 = $360 over 12 months (our calculation)

The prepaid plan delivers the advertised savings only if the patient completes four consecutive quarters and the promotional rate remains available. If the promotion ends after the first quarter, subsequent quarters would renew at the standard month-to-month rate unless BrightMeds offers a grandfathering policy. We found no published guarantee of rate continuity in the supplied sources.

Like-for-like comparison: BrightMeds vs PlexusDx three-month plans

PlexusDx offers three-month commitment pricing for both semaglutide and tirzepatide injection, billed monthly rather than upfront. The following comparison holds commitment length constant and shows effective monthly cost over 12 months. All PlexusDx totals are our calculation.

12-month totals are our calculation. BrightMeds charges $297 or $357 upfront per quarter; PlexusDx bills $169 or $269 monthly on a three-month commitment. BrightMeds pricing is labeled as a state-limited summer promotion; PlexusDx pricing is standard as of September 4, 2026.

BrightMeds' promotional prepaid plan offers a substantial price advantage over PlexusDx's three-month commitment for both semaglutide and tirzepatide. However, the comparison involves a structural difference: BrightMeds requires $297 or $357 upfront each quarter, while PlexusDx spreads the commitment across monthly bills. Patients who prefer monthly cash flow or who cannot prepay a full quarter may find the billing structure more important than the nominal rate difference.

Full PlexusDx pricing context

PlexusDx offers three commitment tiers for compounded semaglutide and tirzepatide injection, all billed monthly:

Semaglutide injection

• Month-to-month: $189/month → $2,268 over 12 months (our calculation)
• Three-month commitment: $169/month → $2,028 over 12 months (our calculation)
• Six-month commitment: $149/month → $1,788 over 12 months (our calculation)

Tirzepatide injection

• Month-to-month: $289/month → $3,468 over 12 months (our calculation)
• Three-month commitment: $269/month → $3,228 over 12 months (our calculation)
• Six-month commitment: $249/month → $2,988 over 12 months (our calculation)

PlexusDx includes the provider visit, prescription, compounded medication, and shipping in each monthly charge; no membership, lab, or visit fees apply. PlexusDx six-month commitment pricing for semaglutide ($1,788 over 12 months) exactly matches BrightMeds' month-to-month annual cost, and PlexusDx six-month tirzepatide ($2,988) falls between BrightMeds' prepaid ($1,428) and month-to-month ($1,788) totals—though BrightMeds remains the lower-cost option in all direct comparisons when the promotional prepaid rate applies.

Decision factors

When upfront cost and promotional pricing matter

BrightMeds' three-month prepaid plan delivers the lowest effective monthly rate among the options compared, provided the patient can prepay $297 or $357 each quarter and the promotional rate remains available for renewals. The $360 annual savings over BrightMeds' own month-to-month plan is meaningful, and the advantage over PlexusDx is larger still. However, the promotional and state-limited nature of the offer introduces uncertainty: if the rate increases after the first quarter, the 12-month savings evaporate. BrightMeds has not published a grandfathering or rate-guarantee policy in the materials we reviewed.

When billing flexibility and rate certainty matter

Patients who prefer predictable monthly expenses or who lack the upfront capital for a full quarter may find BrightMeds' month-to-month plan or PlexusDx's commitment plans more practical. BrightMeds' month-to-month rate ($129 semaglutide, $149 tirzepatide) still undercuts PlexusDx across all commitment tiers, but the gap narrows: PlexusDx six-month semaglutide at $149/month equals BrightMeds' tirzepatide month-to-month rate and costs the same annually as BrightMeds semaglutide month-to-month. PlexusDx pricing is not labeled promotional and carries no state restriction, which may offer more rate predictability over a long treatment course.

Service quality and support

BrightMeds holds a 4.8-star rating on Trustpilot with over 900 reviews (captured September 4, 2026). PlexusDx holds a 4.2-star rating on Trustpilot, with 76% of reviews at five stars and 81% at four stars or higher (captured September 4, 2026). Both programs include ongoing provider support, follow-up visits, and dose adjustments in their published pricing. We found no documented negative service themes for BrightMeds in the review pass; patients should review recent feedback on Trustpilot to assess current satisfaction trends.

Cancellation, refunds, and transfer logistics

Neither BrightMeds nor PlexusDx publishes a refund policy for prepaid periods in the sources we reviewed. Patients considering BrightMeds' prepaid plan should confirm at enrollment whether unused months are refundable if they discontinue treatment mid-quarter, and whether they can transfer an active prescription to another provider or pharmacy if they leave the program. PlexusDx monthly billing limits financial exposure to one month if a patient cancels, but commitment plans may carry early-termination terms that should be confirmed before enrollment.

Choose BrightMeds three-month prepaid if…

• You can prepay $297 (semaglutide) or $357 (tirzepatide) upfront each quarter and want the lowest effective monthly rate available in this comparison.
• The promotional offer is available in your state and you accept the risk that the rate may not be guaranteed beyond the current enrollment period.
• You prioritize immediate cost savings over billing flexibility and are comfortable with the upfront cash commitment.
• You value BrightMeds' 4.8-star Trustpilot rating and prefer a provider with a large volume of recent positive reviews.

Choose BrightMeds month-to-month if…

• You want BrightMeds' lower pricing without the upfront quarterly commitment.
• You prefer predictable monthly billing and the flexibility to pause or cancel with minimal financial exposure.
• You are starting GLP-1 treatment and want to assess medication tolerance and service quality before committing to a longer prepaid period.
• The $129 semaglutide or $149 tirzepatide monthly rate fits your budget and still undercuts most competing month-to-month plans.

Choose PlexusDx if…

• You prefer monthly billing across all commitment tiers and want to avoid upfront quarterly charges.
• You value transparent, non-promotional pricing with no state restrictions or seasonal offer dependencies.
• You are comparing multiple medication options—including oral semaglutide, oral tirzepatide, or microdose GLP-1—and want a single provider offering the full range under one intake and support system.
• You want the option to lock in a six-month rate ($149 semaglutide, $249 tirzepatide) that remains below most competitors' standard pricing and matches or beats BrightMeds' month-to-month rates for semaglutide.

Methodology and freshness

We captured BrightMeds pricing, inclusions, and promotional terms from the provider's public pricing page and marketing materials on September 4, 2026, at 13:49:55 UTC. BrightMeds review data (Trustpilot 4.8 stars, 900+ reviews) was captured the same day. PlexusDx pricing is current as of September 4, 2026; PlexusDx review data (Trustpilot 4.2 stars, 76% five-star, 81% four-star or higher) was captured September 4, 2026.

All 12-month cost totals, effective monthly rates for prepaid plans, and savings calculations are our own arithmetic, clearly labeled throughout the article. We compared like commitment lengths (three-month plans) and calculated annual totals assuming continuous treatment with no gaps, price changes, or promotional lapses. BrightMeds' prepaid rates ($99 and $119) are our calculation, derived by dividing the quarterly upfront charge by three months; the actual billing event is the $297 or $357 quarterly charge.

We did not find published cancellation, refund, grandfathering, or rate-guarantee policies for BrightMeds in the sources reviewed. Patients should confirm these terms, state availability, and promotional rate continuity directly with BrightMeds before enrollment. No insurance, reimbursement, or third-party discount data is included; all figures reflect direct-pay cash pricing.

Frequently Asked Questions

Is BrightMeds' $99/month semaglutide rate guaranteed for 12 months?

The $99/month prepaid rate ($297 upfront per quarter) is described as a state-limited summer promotion captured September 4, 2026. BrightMeds has not published a rate guarantee or grandfathering policy for promotional pricing in the sources we reviewed. Confirm renewal terms at enrollment to understand whether the rate will hold for subsequent quarters.

Can I get a refund if I prepay three months and stop treatment early?

BrightMeds' refund policy for prepaid periods is not documented in the materials we reviewed. Before enrolling in the three-month prepaid plan, ask BrightMeds directly whether unused months are refundable if you discontinue treatment, experience intolerable side effects, or need to transfer care to another provider mid-quarter.

Does PlexusDx offer a prepaid discount to match BrightMeds?

No. PlexusDx pricing is structured around monthly billing on month-to-month, three-month, or six-month commitments; no upfront prepayment discount is offered. PlexusDx six-month semaglutide at $149/month totals $1,788 over 12 months (our calculation), which equals BrightMeds' semaglutide month-to-month annual cost but remains higher than BrightMeds' prepaid promotional plan.

What happens if BrightMeds' promotional rate ends after my first quarter?

If the promotional rate is discontinued, your renewal would likely occur at the standard month-to-month rate ($129 semaglutide, $149 tirzepatide) unless BrightMeds offers a grandfathering provision. The 12-month savings we calculated assume the promotional rate remains available for four consecutive quarters. Confirm the provider's policy on promotional rate continuity before committing.

Are compounded semaglutide and tirzepatide branded products?

No. Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. Compounded semaglutide and tirzepatide are not interchangeable with FDA-approved branded products such as Ozempic, Wegovy, Mounjaro, or Zepbound.

Sources

• PlexusDx Weight Management Protocols – pricing and commitment options; accessed September 4, 2026
• BrightMeds Pricing Page – three-month prepaid and month-to-month rates for semaglutide and tirzepatide injection; accessed September 4, 2026, 13:49:55 UTC
• BrightMeds Promotional Materials – state-limited summer offer terms; accessed September 4, 2026, 13:49:55 UTC
• Trustpilot – BrightMeds provider profile (4.8 stars, 900+ reviews); PlexusDx profile (4.2 stars, 76% five-star, 81% four-star or higher); accessed September 4, 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.